Return to the Faculty List

Ginger Nicol, MD

Current Position
Assistant Professor of Psychiatry (Child)

Education and Training
Undergraduate: B.A. Journalism & Mass Communications, University of Iowa, 1998
Graduate: MD, University of Iowa Carver College of Medicine, 2002
Residency: Washington University School of Medicine, General Psychiatry, 2005
Fellowship: Washington University School of Medicine, Child and Adolescent Psychiatry, 2007
Post-Doctoral: NIDA Research Fellowship, Biomedical Research Training in Drug Abuse, 2010

Major Awards
Eli Robins Award for Excellence in Clinical Psychiatry, Teaching and Research, 2007
Mortimer Goodman Award for Outstanding Contribution to Mental Health through MO NAMI, 2014

Areas of Clinical Interest
Obesity and metabolic outcomes in mentally ill individuals, childhood disruptive behavior and mood disorders, Schizophrenia


Areas of Research Interests
Identification and prevention of cardiometabolic risk in mentally ill populations, psychopharmacology, treatment of obesity and eating disorders.

More articles and abstracts at the National Library of Medicine

Key Publications
Nicol G, Worsham E, Haire-Joshu D, Duncan A, Schweiger J, Yingling M, Lenze E, (2016 Feb).Getting to More Effective Weight Management in Antipsychotic-Treated Youth: A Survey of Barriers and Preferences.Child Obes. 12(1): 70-6.  Full Article ->

Nicol GE, de Las Fuentes L, Riek AE, Bernal-Mizrachi C, Lenze EJ, Miller JP, Schweiger JA, Yingling MD, Huang VJ, Dixon DJ, Hennekens CH, Newcomer JW, (2015 Sep).Adiposity and Cardiometabolic Risk in Children With and Without Antipsychotic Drug Treatment.J. Clin. Endocrinol. Metab.. 100(9): 3418-26.  Full Article ->

Morrato EH, Nicol GE, Maahs D, Druss BG, Hartung DM, Valuck RJ, Campagna E, Newcomer JW, (2010 Apr).Metabolic screening in children receiving antipsychotic drug treatment.Arch Pediatr Adolesc Med. 164(4): 344-51.  Full Article ->

Nicol GE, Morrato EH, Johnson MC, Campagna E, Yingling MD, Pham V, Newcomer JW. Best practices: implementation of a glucose screening program based on diffusion of innovation theory methods. Psychiatr Serv. 2011 Jan;62(1):12-4.  Full Article ->

Gohlke JM, Dhurandhar EJ, Correll CU, Morrato EH, Newcomer JW, Remington G, Nasrallah HA, Crystal S, Nicol G, Adipogenic and Metabolic Effects of APDs Conference Speakers, Allison DB (2012). Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs. Front Psychiatry. 362.  Full Article ->

Nicol GE, Campagna EJ, Garfield LD, Newcomer JW, Parks JJ, Morrato EH, (2016 Jan).The Role of Clinical Setting and Management Approach in Metabolic Testing Among Youths and Adults Treated With Antipsychotics.Psychiatr Serv. 67(1): 128-32.  Full Article ->

Funded Research Projects
1. Co-Principal Investigator, Otuska America funded Investigator Initiated Clinical Trial, Collaborative Protocol Number #031-104-00014: An Open-label, Multi-center, Longitudinal, Within-subject Comparison Study to Evaluate the Effects of Aripiprazole Once Monthly in Subjects with Schizophrenia on 30-, 90- and 180-day Re-hospitalization Rates Following Hospital Discharge Compared with Retrospective Re-hospitalization Rates while on Oral Antipsychotic Medication
2. Consultant (PI: Zohreh Talebizadeh, PhD) Patient-Centered Outcomes Research Institute (PCORI); Incorporating Genetic Data in PCOR studies: Building a Roadmap for Stakeholder Engagement